Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Surgical Oncology

• Publication date

  2011-03-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-011-1638-yPMID 21416156
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy

  2008cited by this paper
• Circulating Cell-Free DNA in Plasma of Locally Advanced Rectal Cancer Patients Undergoing Preoperative Chemoradiation: A Potential Diagnostic Tool for Therapy Monitoring

  2008cited by this paper
• Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy

  2008cited by this paper
• Effect of Adjuvant Chemotherapy on Integrity of Free Serum DNA in Patients with Breast Cancer

  2008cited by this paper
• Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance.

  2007influential reference
• The genetic basis of tissue responses to ionizing radiation.

  2007cited by this paper
• The Potential of Restaging in the Prediction of Pathologic Response After Preoperative Chemoradiotherapy for Rectal Cancer

  2007cited by this paper
• Circulating nucleic acids in plasma/serum

  2007cited by this paper
• Chemotherapy with Preoperative Radiotherapy in Rectal Cancer

  2007cited by this paper
• Prediction of breast tumor progression by integrity of free circulating DNA in serum.

  2006cited by this paper
• Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients.

  2006influential reference
• Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

  2006cited by this paper
• Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats.

  2006cited by this paper
• Increased plasma DNA integrity index in head and neck cancer patients

  2006cited by this paper
• ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

  2006cited by this paper
• Chemotherapy with preoperative radiotherapy in rectal cancer.

  2006cited by this paper
• Quantification of Total Plasma Cell‐Free DNA in Ovarian Cancer Using Real‐Time PCR

  2006cited by this paper
• Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancer

  2005cited by this paper
• Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid Neoplasias

  2005cited by this paper
• Preoperative versus postoperative chemoradiotherapy for rectal cancer.

  2004cited by this paper
• Allelic Imbalance on 12q22-23 in Serum Circulating DNA of Melanoma Patients Predicts Disease Outcome

  2004cited by this paper
• Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results

  2004cited by this paper
• Colon and rectal surgery without mechanical bowel preparation: a randomized prospective trial. Ann Surg 2003; 237:363-367.

  2004cited by this paper
• Circulating nucleic acids in plasma and serum: past, present and future.

  2004cited by this paper
• Commented Summaries

  2004cited by this paper
• Circulating Nucleic Acids and Proteomics of Plasma/Serum: Clinical Utility

  2004cited by this paper
• Colon and Rectal Surgery Without Mechanical Bowel Preparation: A Randomized Prospective Trial

  2003cited by this paper
• Increased plasma DNA integrity in cancer patients.

  2003cited by this paper
• About the possible origin and mechanism of circulating DNA apoptosis and active DNA release.

  2001cited by this paper
• Alu Repeat Sequences Are Present in Increased Proportions Compared to a Unique Gene in Plasma/Serum DNA

  2001cited by this paper
• DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

  2001cited by this paper
• Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers.

  2000cited by this paper
• Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls.

  1998cited by this paper
• Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations

  1994cited by this paper
• Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.

  1992cited by this paper

• Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside Implementations

  2025cites this paper
• Circulating Cell Free DNA and DNA Double-Strand Breakage in Alzheimer’s Disease

  2024cites this paper
• Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis

  2024cites this paper
• Machine learning to detect the SINEs of cancer

  2024cites this paper
• ctDNA as a predictor of outcome after curative resection for locally advanced rectal cancer: systematic review and meta‐analysis

  2024influential citation
• Evaluation of Changes in Circulating Cell-Free DNA as an Early Predictor of Response to Chemoradiation in Rectal Cancer—A Pilot Study

  2023cites this paper
• Minimal Residual Disease in Colorectal Cancer: Are We Finding the Needle in a Haystack?

  2023cites this paper
• Ω-shaped fiber optic LSPR biosensor based on mismatched hybridization chain reaction and gold nanoparticles for detection of circulating cell-free DNA.

  2023cites this paper
• The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer

  2023cites this paper
• Case Analysis of Cancer Patients Undergoing Genetic Testing in a General Hospital in Northern Shaanxi from 2017 to 2020

  2023cites this paper
• A Review of Circulating Tumor DNA as a Biomarker Guide for Total Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer

  2023cites this paper
• Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses

  2023cites this paper
• Emerging Applications of Liquid Biopsies in Ovarian Cancer

  2023cites this paper
• Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis

  2023influential citation
• Prognostic microRNAs as biomarkers for prostate cancer

  2023cites this paper
• Amino Acid Profiles in the Biological Fluids and Tumor Tissue of CRC Patients

  2023cites this paper
• Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

  2023cites this paper
• Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy

  2022cites this paper
• Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management

  2022cites this paper
• Circulating cell-free-DNA concentration is a good biomarker for diagnosis of colorectal cancer in Mexican patients.

  2022influential citation
• Clinical Utility of Circulating Tumor Cells for Predicting Major Histopathological Response after Neoadjuvant Chemoradiotherapy in Patients with Esophageal Cancer

  2022cites this paper
• Predicting neoadjuvant chemoradiotherapy response with functional imaging and liquid biomarkers in locally advanced rectal cancer

  2022cites this paper
• Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis

  2022cites this paper
• The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies

  2022cites this paper
• Potential clinical utility of liquid biopsies in ovarian cancer

  2022cites this paper
• Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models

  2022cites this paper
• Circulating Cell Free DNA Integrity Index as a Biomarker for Response to Chemotherapy in Patients with Metastatic Colorectal Carcinoma

  2022cites this paper
• Mucinous Colorectal Cancer Oxidative Stress and Therapeutic MicroRNAs

  2022cites this paper
• Reduced Serum Circulation of Cell-Free DNA Following Chemotherapy in Breast Cancer Patients

  2021cites this paper
• Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients

  2021cites this paper
• Cell-Free DNA: Hope and Potential Application in Cancer

  2021cites this paper
• Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer

  2021cites this paper
• Fragmentation Analysis of Plasma DNA Reveals Its Prognostic Value in Gastric Cancer.

  2021cites this paper
• Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma

  2021cites this paper
• Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer

  2021cites this paper
• ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review.

  2021cites this paper
• Biomarkers as Putative Therapeutic Targets in Colorectal Cancer

  2021cites this paper
• Involvement of Circulating Cell-Free Mitochondrial DNA and Proinflammatory Cytokines in Pathogenesis of Chronic Obstructive Pulmonary Disease and Lung Cancer

  2021cites this paper
• Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer?

  2021cites this paper
• Different Mechanism Involvement in the Formation of Colorectal Cancer; Mega Review

  2021cites this paper
• Evaluation of Plasma Circulating Cell Free DNA Concentration and Integrity in Patients with Prostate Cancer in Jamaica: A Preliminary Study

  2020cites this paper
• Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta‐analysis

  2020cites this paper
• Clinical value of tissue DNA integrity index in pancreatic cancer.

  2020cites this paper
• Cell free DNA as an evolving liquid biopsy biomarker for initial diagnosis and therapeutic nursing in Cancer- An evolving aspect in Medical Biotechnology.

  2020cites this paper
• Accurate prediction of RNA 5-hydroxymethylcytosine modification by utilizing novel position-specific gapped k-mer descriptors

  2020cites this paper
• Exploration of the Beta-Actin DNA Integrity Index as Early Genetic Marker of Presence of Breast Cancer

  2020cites this paper
• Simultaneous Isolation of Circulating Nucleic Acids and EV-Associated Protein Biomarkers From Unprocessed Plasma Using an AC Electrokinetics-Based Platform

  2020cites this paper
• The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer

  2020cites this paper
• Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response

  2020cites this paper
• Life and death of circulating cell-free DNA

  2019cites this paper
• Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma

  2019cites this paper
• Promising member of the short interspersed nuclear elements (Alu elements): mechanisms and clinical applications in human cancers

  2019cites this paper
• Nonsurgical Management of Rectal Cancer.

  2019cites this paper
• Translational Research in Colorectal Cancer: Current Status and Future Perspectives of Multimodal Treatment Approach

  2019cites this paper
• Circulating biomarkers for response prediction of rectal cancer to neoadjuvant chemoradiotherapy.

  2019cites this paper
• Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.

  2019cites this paper
• Circulating cell-free long DNA fragments predict post-hepatectomy recurrence of colorectal liver metastases.

  2019cites this paper
• Liquid biopsy for rectal cancer: A systematic review.

  2019cites this paper
• Novel biomarkers for the diagnosis and prognosis of colorectal cancer

  2019cites this paper
• Association of Observed Perioperative Cell-Free DNA Dynamics With Early Recurrence in Patients With Colon Cancer.

  2019cites this paper
• Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer

  2019cites this paper
• Expert in the field of circulating biomarkers for GI tumors

  2019influential citation
• Circulating biomarkers as prognostic and predictive markers in rectal cancer

  2019influential citation
• Should Liquid Biopsies Be Considered in Treatment Decisions

  2018cites this paper
• Application and optimization of minimally invasive cell-free DNA techniques in oncogenomics

  2018cites this paper
• DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNA.

  2018cites this paper
• Cell-free DNA and preoperative chemoradiotherapy for rectal cancer: a systematic review

  2018cites this paper
• Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review

  2018cites this paper
• Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis

  2018cites this paper
• Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives

  2018cites this paper
• Analysis of solid tumor mutation profiles in liquid biopsy

  2018cites this paper
• KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

  2018cites this paper
• Circulating tumour DNA, a promising biomarker for the management of colorectal cancer.

  2018cites this paper
• Efficacy of assessing circulating cell-free DNA using a simple fluorescence assay in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a prospective observational study

  2017cites this paper
• Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index

  2017cites this paper
• Cell-free DNA levels and correlation to stage and outcome following treatment of locally advanced rectal cancer

  2017cites this paper
• LEVEL OF CIRCULATING CELL-FREE DNA IN THE SERUM OF EGYPTIAN PATIENTS AS A BIOMARKER FOR DIAGNOSIS AND PROGNOSTIC PREDICTION OF COLORECTAL CANCER

  2017influential citation
• The clinical role of circulating free tumor DNA in gastrointestinal malignancy

  2017cites this paper
• Cell-Free DNA Profile in Peri-Implant Skin Exudate of Craniofacial Implants with Various Degrees of Inflammation: A Pilot Study.

  2017cites this paper
• Biomarkers that Predict Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

  2017cites this paper
• Organ preservation in rectal cancer – Challenges and future strategies

  2017cites this paper
• Circulating tumor cells in thyroid carcinoma - the prognostic role of this biomarker. Review of the literature

  2017cites this paper
• Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer

  2017cites this paper
• Diagnostic and prognostic role of cell‐free DNA testing for colorectal cancer patients

  2017cites this paper
• Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.

  2017influential citation
• CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA

  2017cites this paper
• Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma

  2016cites this paper
• Investigation of Efficacy Evaluation Comparison of cfDNA and CEA in Colorectal Cancer.

  2016cites this paper
• The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis

  2016cites this paper
• Increased Free Circulating DNA Integrity Index as a Serum Biomarker in Patients with Colorectal Carcinoma.

  2016cites this paper
• A Methylation Profile of Circulating Cell Free DNA for the Early Detection of Gastric Cancer and the Effects after Surgical Resection

  2016cites this paper
• The impact of age on the postprandial metabolomic and inflammatory responses to a breakfast meal

  2015cites this paper
• Evaluation of cell-free DNA as a biomarker for pancreatic malignancies

  2015cites this paper
• Regulation of cancer metastasis by cell-free miRNAs.

  2015cites this paper
• Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer

  2015cites this paper
• Circulating DNA in Cancer: An Overview

  2015cites this paper
• Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.

  2015cites this paper
• Recent advances in clinical applications of circulating cell-free DNA integrity.

  2014cites this paper
• Circulating Free DNA in a Screening Program for Early Colorectal Cancer Detection

  2014cites this paper
• Circulating Cell Free DNA as Blood Based Biomarker in Breast Cancer

  2014cites this paper